|
PRPS1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.627400E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.58510999999084E-05 |
| Normal-vs-Stage2 |
7.808400E-01 |
| Normal-vs-Stage3 |
7.710400E-01 |
| Normal-vs-Stage4 |
1.183640E-01 |
| Stage1-vs-Stage2 |
2.557800E-01 |
| Stage1-vs-Stage3 |
3.168200E-02 |
| Stage1-vs-Stage4 |
8.412600E-01 |
| Stage2-vs-Stage3 |
9.113400E-01 |
| Stage2-vs-Stage4 |
4.216200E-01 |
| Stage3-vs-Stage4 |
2.370600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.15079999999324E-05 |
| Normal-vs-AfricanAmerican |
3.066800E-01 |
| Normal-vs-Asian |
5.076800E-01 |
| Caucasian-vs-AfricanAmerican |
2.654800E-01 |
| Caucasian-vs-Asian |
8.715000E-01 |
| AfricanAmerican-vs-Asian |
8.027400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.26460000249295E-08 |
| Normal-vs-Female |
2.237000E-01 |
| Male-vs-Female |
1.85083999999502E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.601900E-02 |
| Normal-vs-Extreme_Weight |
3.72439999996033E-06 |
| Normal-vs-Obese |
3.652000E-01 |
| Normal-vs-Extreme_Obese |
4.521500E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.260800E-01 |
| Normal_Weight-vs-Obese |
3.873800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.647240E-01 |
| Extreme_Weight-vs-Obese |
2.633800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.624200E-01 |
| Obese-vs-Extreme_Obese |
8.468200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.811600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.100000E-02 |
| Normal-vs-Age(61-80Yrs) |
7.81130000000463E-05 |
| Normal-vs-Age(81-100Yrs) |
1.850010E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.352050E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.111500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.304400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.320800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.440800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.520600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.20540000001246E-06 |
| Normal-VS-Type2 PRCC |
1.505170E-01 |
| Normal-VS-KIRP CIMP |
2.975000E-01 |
| Normal-VS-Unclassified PRCC |
3.217600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.410100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.218500E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
9.475500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.246300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.758400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.014970E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.526180E-02 |
| Normal-vs-N1 |
9.895000E-01 |
| Normal-vs-N2 |
7.485400E-01 |
| N0-vs-N1 |
1.220000E-01 |
| N0-vs-N2 |
2.790000E-01 |
| N1-vs-N2 |
7.459800E-01 |
|
|
